![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
X
20
Sterling Biotech Limited Masar Village In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Lovastatin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2014-146 - Rev 00
This Chemical Type CEP, issued on March 16, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1538 associated with this CEP further emphasizes